GenSight Biologics Company
Age-related disease / Mitochondria
Investors
Technology:
Neurological Disorders
Industry:
Gene Therapy
Headquarters:
Paris, Ile-de-France, France
Founded Date:
2012
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Register and Claim Ownership